2024年11月25日 · CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.

2024年10月3日 · UnitedHealthcare is adding deductibles to Part D prescriptions on certain formulary tiers as a result of plan design changes from the Inflation Reduction Act.

2024年12月9日 · Beginning Jan. 1, 2025, Optum Rx will prefer a different set of Humira biosimilar on its commercial formularies. UnitedHealth Group’s pharmacy benefit manager (PBM), one of the three largest in the United States, is favoring Amgen’s Amjevita (adalimumab-atto) over Sandoz’s Hyrimoz (adalimumab-adaz) and Cyltezo (adalimumab-adbm).

2024年10月21日 · Technology can help address the complexities of specialty medications by automating processes and enabling proactive interventions to ensure patients stay on their critical therapies, according to Kristen Whelchel, Pharm.D., CSP, Research and Patient Care Improvement Pharmacist with Vanderbilt Specialty Pharmacy's Department of Health Outcomes and …

2024年10月1日 · In 2025, Aetna, the health insurance company of CVS Health, has added several new programs to Medicare for 2025. Aetna will launch new Chronic Condition Special Needs Plans (C-SNPs) in Illinois (Chicago) and Pennsylvania (Philadelphia and Pittsburgh).

2025年1月1日 · Loren McCaghy of Accenture Suggests Digital Engagement, Ease of Use as Key Drivers in Healthcare Provider and Payer Turnover In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest ...

2024年9月16日 · Prime, headquartered in Eagan, Minnesota, is one of six largest pharmacy benefit managers (PBMs) in the country, an industry that has come under increasing criticism and scrutiny for its business practices and vertical and horizontal consolidation trends.

2024年8月27日 · “In a clinical study, the 5 mg maintenance dose helped patients achieve an average of 15% weight loss after 72 weeks of treatment and has been a powerful tool for millions of people with obesity looking to lose weight and keep it off,” Patrik Jonsson, executive vice president, and president of Lilly Cardiometabolic Health and Lilly USA, said in a news release.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

2024年12月9日 · Suzetrigine, a non-opioid currently being reviewed by U.S. regulators to treat acute pain, would provide small savings and help patients avoid the use of opioids, according to a draft evidence report from the Institute Clinical and Economic Review (ICER).